It was shown that the main molecular basis of CML pathogenesis is the translocation between the arms of chromosomes 9 and 22, leading to the creation of chromosome Philadelphia and BCR-ABL1 gene fusion (~95% of CML patients) [20]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.